Citations

Showing 10 of 108162 citations.

Route of Hysterectomy: Robotic
Chen, Anita H. , Robertson, Matthew

Mayo Clinic

Journal of Gynecologic Surgery | April 1, 2021 | Volume: 37 | Issue: 2 | Pages: 112-115

10.1089/gyn.2020.0238 Get It

Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
Ledet, Elisa M. , Burgess, Earle F. , Sokolova, Alexandra , Jaeger, Ellen , Hatton, Whitley, Moses, Marcus W., Cotogno, Patrick, Layton, Jodi Lyn , Dellinger, Beth, Elrefai, Sara, Nafissi, Nellie , Egan, Jan B. , McKay, Rana R. , Bryce, Alan H. , Cheng, Heather H. , Antonarakis, Emmanuel S. , Antonarakis, Emmanuel S. , Nafissi, Nellie N , Bryce, Alan H , Cheng, Heather H , Antonarakis, Emmanuel S , Sartor, A Oliver , Ledet, Elisa , Antonarakis, Emmanuel S , Jaeger, Ellen B , Miller, Patrick, Barata, Pedro C. , Lewis, Brian E. , Nakazawa, Mari , Zhu, Jason , Shore, Neal D. , Sartor, Oliver

Mayo Clinic

The Prostate | April 1, 2021 | Volume: 81 | Issue: 7 | Pages: 433-439

10.1002/pros.24123 | PMID 33792945 Get It

AbstractBackgroundThe goal of this study is to evaluate germline genetic variants in African American men with metastatic prostate cancer as compared to those in Caucasian men with metastatic prostate cancer in an effort to understand the role of genetic factors in these populations.MethodsAfrican American and Caucasian men with metastatic prostate cancer who had germline testing using multigene panels were used to generate comparisons. Germline genetic results, clinical parameters, and family histories between the two populations were analyzed.ResultsA total of 867 patients were included in this retrospective study, including 188 African American and 669 Caucasian patients. There was no significant difference in the likelihood of a pathogenic or likely‐pathogenic variants (PV/LPVs) between African American and Caucasian patients (p = .09). African American patients were more likely to have a variant of unknown significance than Caucasians (odds ratio [OR] = 1.95; p < .0001). BRCA1 PV/LPVs were higher in African Americans (OR = 4.86; p = .04). African American patients were less likely to have a PV/LPV in non‐BRCA DNA repair genes (OR = 0.30; p = .008). Family history of breast (OR = 2.09; p = .002) or ovarian cancer (OR = 2.33; p = .04) predicted PV/LPVs in Caucasians but not African‐Americans. This underscores the limitations of family history in AA men and the importance of personal history to guide germline testing in AA men.ConclusionsIn metastatic prostate cancer patients, PV/LPVs of tested genes did not vary by race, BRCA1 PV/LPVs were more common in the African American subset. However, PV/LPVs in non‐BRCA DNA repair genes were less likely to be encountered in African Americans. Family history associated with genetic testing results in Caucasians only.
Calibration of a versatile multi-energy soft x-ray diagnostic for WEST long pulse plasmas
Chellaï, O. , Delgado-Aparicio, L. , VanMeter, P. , Barbui, T. , Wallace, John , Hill, K. W. , Pablant, N. , Stratton, B. , Disch, C., Luethi, B., Pilet, N.

Mayo Clinic

Review of Scientific Instruments | April 1, 2021 | Volume: 92 | Issue: 4 | Pages: No page available

10.1063/5.0043456 | PMID 34243460 Get It

A compact multi-energy soft x-ray diagnostic is being installed on the W Environment in Steady-state Tokamak (WEST), which was designed and built to test ITER-like tungsten plasma facing components in a long pulse (∼1000 s) scenario. The diagnostic consists of a pinhole camera fielded with the PILATUS3 photon-counting Si-based detector (≲100 kpixel). The detector has sensitivity in the range 1.6–30 keV and enables energy discrimination, providing a higher energy resolution than conventional systems with metal foils and diodes with adequate space and time resolution (≲1 cm and 2 ms). The lower-absorption cut-off energy is set independently on each one of the ∼100 kpixels, providing a unique opportunity to measure simultaneously the plasma emissivity in multiple energy ranges and deduce a variety of plasma parameters (e.g., Te, nZ, and ΔZeff). The energy dependence of each pixel is calibrated here over the range 3–22 keV. The detector is exposed to a variety of monochromatic sources—fluorescence emission from metallic targets—and for each pixel, the lower energy threshold is scanned to calibrate the energy dependence. The data are fit to a responsivity curve (“S-curve”) that determines the mapping between the possible detector settings and the energy response for each pixel. Here, the calibration is performed for three energy ranges: low (2.3–6 keV), medium (4.5–13.5 keV), and high (5.4–21 keV). We determine the achievable energy resolutions for the low, medium, and high energy ranges as 330 eV, 640 eV, and 950 eV, respectively. The main limitation for the energy resolution is found to be the finite width of the S-curve.
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Fuchs, Charles S. , Shitara, Kohei , Muro, Kei , Vita, Ferdinando De , Landers, Gregory, Yen, Chia‐Jui , Chau, Ian , Elme, Anneli , Lee, Jeeyun , Özgüroğlu, Mustafa , Catenacci, Daniel V.T. , Yoon, Harry H. , Chen, Erluo, Adelberg, David E., Shih, Chie‐Schin , Shah, Sukrut, Bhagia, Pooja , Yen, Chia-Jui , Özgüroğlu, Mustafa , Chao, Joseph , Tabernero, Josep , Cutsem, Eric Van , Bang, Yung‐Jue , Wainberg, Zev A.

Mayo Clinic

JAMA Oncology | April 1, 2021 | Volume: 7 | Issue: 6 | Pages: 895

10.1001/jamaoncol.2021.0275 | PMID 33792646 Get It

In Response to Regarding Cricopharyngeal Myotomy in IBM: Comparison of Endoscopic and Transcervical Approaches
McMillan, Ryan A. , Bayan, Semirra L. , Kasperbauer, Jan L. , Ekbom, Dale C. , Crum, Brian A. , Kasperbauer, Jan , Ekbom, Dale , McMillan, Ryan A , Bayan, Semirra , Bowen, Andrew J.

Mayo Clinic

The Laryngoscope | April 1, 2021 | Volume: 131 | Issue: 6 | Pages: No page available

10.1002/lary.29544 | PMID 33792935 Get It

Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications
Cifuentes, Lizeth , Camilleri, Michael , Acosta, Andrés

Mayo Clinic

Nutrients | April 1, 2021 | Volume: 13 | Issue: 4 | Pages: 1158

10.3390/nu13041158 | PMID 33915747 Get It

Sensory and motor functions of the stomach, including gastric emptying and accommodation, have significant effects on energy consumption and appetite. Obesity is characterized by energy imbalance; altered gastric functions, such as rapid gastric emptying and large fasting gastric volume in obesity, may result in increased food intake prior to reaching usual fullness and increased appetite. Thus, many different interventions for obesity, including different diets, anti-obesity medications, bariatric endoscopy, and surgery, alter gastric functions and gastrointestinal motility. In this review, we focus on the role of the gastric and intestinal functions in food intake, pathophysiology of obesity, and obesity management.
An Unusual Pattern on Overnight Oximetry in a Child with Refractory Epilepsy
Verma, Rahul , Nouri, Maryam Nabavi , Wiedermann, Joshua P. , St‐Laurent, Aaron

Mayo Clinic

Annals of the American Thoracic Society | April 1, 2021 | Volume: 18 | Issue: 4 | Pages: 714-716

10.1513/annalsats.202009-1156cc | PMID 33792517 Get It

Association between primary care physician diagnostic knowledge and death, hospitalisation and emergency department visits following an outpatient visit at risk for diagnostic error: a retrospective cohort study using medicare claims
Gray, Bradley M. , Vandergrift, Jonathan L. , McCoy, Rozalina G. , Lipner, Rebecca S. , McCoy, Rozalina Grubina , Landon, Bruce E.

Mayo Clinic

BMJ Open | April 1, 2021 | Volume: 11 | Issue: 4 | Pages: e041817

10.1136/bmjopen-2020-041817 | PMID 33795293 Get It

Objective Diagnostic error is a key healthcare concern and can result in substantial morbidity and mortality. Yet no study has investigated the relationship between adverse outcomes resulting from diagnostic errors and one potentially large contributor to these errors: deficiencies in diagnostic knowledge. Our objective was to measure that associations between diagnostic knowledge and adverse outcomes after visits to primary care physicians that were at risk for diagnostic errors. Setting/participants 1410 US general internists who recently took their American Board of Internal Medicine Maintenance of Certification (ABIM-IM-MOC) exam treating 42 407 Medicare beneficiaries who experienced 48 632 ‘index’ outpatient visits for new problems at risk for diagnostic error because the presenting problem (eg, dizziness) was related to prespecified diagnostic error sensitive conditions (eg, stroke). Outcome measures 90-day risk of all-cause death, and, for outcome conditions related to the index visits diagnosis, emergency department (ED) visits and hospitalisations. Design Using retrospective cohort study design, we related physician performance on ABIM-IM-MOC diagnostic exam questions to patient outcomes during the 90-day period following an index visit at risk for diagnostic error after controlling for practice characteristics, patient sociodemographic and baseline clinical characteristics. Results Rates of 90-day adverse outcomes per 1000 index visits were 7 for death, 11 for hospitalisations and 14 for ED visits. Being seen by a physician in the top versus bottom third of diagnostic knowledge during an index visit for a new problem at risk for diagnostic error was associated with 2.9 fewer all-cause deaths (95% CI −5.0 to −0.7, p=0.008), 4.1 fewer hospitalisations (95% CI −6.9 to −1.2, p=0.006) and 4.9 fewer ED visits (95% CI −8.1% to −1.6%, p=0.003) per 1000 visits. Conclusion Higher diagnostic knowledge was associated with lower risk of adverse outcomes after visits for problems at heightened risk for diagnostic error.
50 A Retrospective Review of Enoxaparin Dosing Practices in Burn Patients
Quan, Asia N , Aden, Aisha, Islas, Claudia, Richey, Karen , Foster, Kevin N

Mayo Clinic

Journal of Burn Care & Research | April 1, 2021 | Volume: 42 | Issue: Supplement_1 | Pages: S37-S37

10.1093/jbcr/irab032.054 Get It

Abstract Introduction Enoxaparin, a low molecular weight heparin, has been proven to safely and effectively prevent venous thromboembolism (VTE) in acutely ill patients. Burn patients may be particularly vulnerable to the occurrence of a VTE due to prolonged immobility, frequent operating room procedures, and low flow states. Treatment of acute VTE is associated with a direct medical cost of $12000-$15000 and subsequent complications increase costs to $18000 to $23000 per case. Current institutional protocol for initiation of enoxaparin an all burn adult patients is 40 mg administered subcutaneously every 12 hours. Anti-Xa levels are used to monitor anticoagulation prophylaxis, with 0.3–0.5 U/mL recognized as the prophylactic range. Doses are subsequently modified in 10 mg increments to achieve goal prophylaxis anti-Xa levels. The purpose of this study was to evaluate current practice (CP) and assess if the implementation of a published enoxaparin dosing algorithm could minimize delay in achieving anticoagulation prophylaxis. Methods A retrospective chart review was performed of 94 adult burn patients. The doses and time required to reach goal prophylaxis anti-Xa levels using current practice (CP) were compared to the predicted algorithm dose (AD). The number of dose adjustments and the number of days needed for adjustments for CP were documented. Charges related for laboratory determinations and medication administration were calculated. Results Of the 94 patients reviewed, the average age was 47 years, the majority were male (74%), mean actual weight 92 kilograms and mean TBSA 15.7%. The most common mechanism of injury was flash/flame (63%) with 18% suffering an inhalation injury. On average, using CP, it took 9.3 days to get to goal prophylaxis anti-Xa levels, with a mean of 2.86 anti-Xa lab tests needed and an average prophylactic dose of 55.5 mg. A total of 360 labs draws were performed and 74% were timed correctly. The CP average starting dose was lower than the AD 40 mg versus 45 mg (p &lt; .0001). If the algorithm had been used the number of dosing adjustments would have been 25% less. The algorithm overestimated the starting dose in only 2.1% of the population. The average charges until goal was met for enoxaparin were $2,933 and $787 for anti-Xa levels. Conclusions This study demonstrates increased clinical efficacy and cost-effectiveness for an algorithm driven enoxaparin dosing regimen for burn patients. Prospective study with larger patient numbers is warranted.
552 Limb Salvage: Amputations Prevented with Dehydrated Human Amnion/Chorion Membrane Allografts (dHACM) Used in Combination with Decellularized Human Collagen Matrix (dHCM)
Matthews, Marc R. , Helmick, Emily, Mellon, Christopher, Thornburg, Danielle A. , Kowal-Vern, Areta , Foster, Kevin N , Tettelbach, William H

Mayo Clinic

Journal of Burn Care & Research | April 1, 2021 | Volume: 42 | Issue: Supplement_1 | Pages: S124-S125

10.1093/jbcr/irab032.202 Get It

Abstract Introduction Burn and traumatic limb injuries with exposed bone/tendon typically require surgical flaps or amputations for healing. Some burn patients are not candidates for these invasive techniques. Placental amniotic membrane has been used as a wound dressing for more than 100 years and may offer an alternative to flaps and/or amputations. Processed dehydrated human amnion/chorion membrane (dHACM), from human placental tissue, contains type 1 human collagen as well as non-viable cells and 285 identified regulatory proteins including growth factors, chemokines, cytokines, metalloproteinases, and other tissue growth and inflammatory mediators. dHACM has been successfully used as a dressing for wound ulcers, burns, donor sites, & surgical debridement. This study reports the use of dHCAM as a limb salvage tool in four patients with severe injuries. Methods This is a retrospective case series of patients suffering severe lower extremity injury with bone/tendon exposure that had applied dHACM/dHCM over or packed (depending on wound depth), then covered with 3% bismuth tribromophenate petrolatum dressing & glycerol/ hydroxyethylcellulose lubricant. Negative pressure wound therapy (NPWT) was initiated; wound re-evaluation occurred in seven days. dHACM/dHCM was reapplied if required (bone still exposed). Results There were 3 males and 1 female with three burns and one NSTI. The mean±sd (median) age was 58±23 (61) years; % total burn surface area 3±3 (2); length of hospital stay 48±30 (40) days; number of tangential excisions & debridements 6.5±1 (6.5); days from admission to product application 49±47 (34) and discharge 24±19 (19) days; negative pressure wound therapy (NPWT) 53±6 (56) days. All four patients continued treatment upon discharge with clinic visits and home NPWT. All recovered with good results and no complications. Treatment may be continued with NPWT therapy at home or in a skilled nursing facility. Patients healed after two to three dHACM/dHCM applications and did not require leg or foot amputations. Conclusions In select limb salvage cases, dHACM/HCM may be a promising alternative to extremity amputations, tissue transfer flaps or other techniques for secondary intention healing of wounds with bone/tendon exposure.